Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
MRSA Drugs Market by MRSA Type (Hospital-Acquired (HA-MRSA), Community-Acquired (CA-MRSA)), Drug Class (Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, and Others), Disease Indication (Skin Infections, Bone and Joint Infections, Bacteremia, Animal Infections), Route of Administration (Oral Administration, Parenteral Administration), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A6905
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global MRSA Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by MRSA Type
6.1 Hospital-Acquired (HA-MRSA)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Community-Acquired (CA-MRSA)
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Lipopeptides
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oxazolidinones
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cephalosporin
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Tetracycline
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Folate Antagonist
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Disease Indication
8.1 Skin Infections
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Bone and Joint Infections
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Bacteremia
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Animal Infections
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Oral Administration
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Parenteral Administration
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Retail Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Online Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 Drivers, Restraints, and Opportunities
12.1 Overview
12.2 Drivers
12.3 Restraints
12.4 Opportunities
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 AbbVie Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Basilea Pharmaceutica Ltd
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Crystal Genomics Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Cumberland Pharmaceuticals Inc
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 Melinta Therapeutics Inc
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 Paratek Pharmaceuticals, Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Pfizer Inc
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
Figure 1: Global: MRSA Drugs Market: Major Drivers and Challenges
Figure 2: Global: MRSA Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: MRSA Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: MRSA Drugs Market: Breakup by MRSA Type (in %), 2023
Figure 5: Global: MRSA Drugs Market: Breakup by Drug Class (in %), 2023
Figure 6: Global: MRSA Drugs Market: Breakup by Disease Indication (in %), 2023
Figure 7: Global: MRSA Drugs Market: Breakup by Route of Administration (in %), 2023
Figure 8: Global: MRSA Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 9: Global: MRSA Drugs Market: Breakup by Region (in %), 2023
Figure 10: Global: MRSA Drugs (Hospital-Acquired (HA-MRSA)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: MRSA Drugs (Hospital-Acquired (HA-MRSA)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: MRSA Drugs (Community-Acquired (CA-MRSA)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: MRSA Drugs (Community-Acquired (CA-MRSA)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: MRSA Drugs (Lipopeptides) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: MRSA Drugs (Lipopeptides) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: MRSA Drugs (Oxazolidinones) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: MRSA Drugs (Oxazolidinones) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: MRSA Drugs (Cephalosporin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: MRSA Drugs (Cephalosporin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: MRSA Drugs (Tetracycline) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: MRSA Drugs (Tetracycline) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: MRSA Drugs (Folate Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: MRSA Drugs (Folate Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: MRSA Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: MRSA Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: MRSA Drugs (Skin Infections) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: MRSA Drugs (Skin Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: MRSA Drugs (Bone and Joint Infections) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: MRSA Drugs (Bone and Joint Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: MRSA Drugs (Bacteremia) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: MRSA Drugs (Bacteremia) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: MRSA Drugs (Animal Infections) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: MRSA Drugs (Animal Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: MRSA Drugs (Oral Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: MRSA Drugs (Oral Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: MRSA Drugs (Parenteral Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: MRSA Drugs (Parenteral Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: MRSA Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: MRSA Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: MRSA Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: MRSA Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: MRSA Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: MRSA Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: North America: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: North America: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: United States: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: United States: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Canada: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Canada: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Asia-Pacific: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Asia-Pacific: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: China: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: China: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Japan: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Japan: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: India: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: India: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: South Korea: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: South Korea: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Australia: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Australia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Indonesia: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Indonesia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Others: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Europe: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Europe: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Germany: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Germany: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: France: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: France: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: United Kingdom: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: United Kingdom: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Italy: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Italy: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Spain: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Spain: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Russia: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Russia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Others: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Latin America: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Latin America: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Brazil: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Brazil: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Mexico: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Mexico: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Others: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Middle East and Africa: MRSA Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: Middle East and Africa: MRSA Drugs Market: Breakup by Country (in %), 2023
Figure 92: Middle East and Africa: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Global: MRSA Drugs Industry: Drivers, Restraints, and Opportunities
Figure 94: Global: MRSA Drugs Industry: Value Chain Analysis
Figure 95: Global: MRSA Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: MRSA Drugs Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: MRSA Drugs Market Forecast: Breakup by MRSA Type (in Million US$), 2024-2032
Table 3: Global: MRSA Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 4: Global: MRSA Drugs Market Forecast: Breakup by Disease Indication (in Million US$), 2024-2032
Table 5: Global: MRSA Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 6: Global: MRSA Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 7: Global: MRSA Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: MRSA Drugs Market: Competitive Structure
Table 9: Global: MRSA Drugs Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More